Insider Selling: LifeStance Health Group, Inc. (NASDAQ:LFST) Insider Sells $130,030.50 in Stock

LifeStance Health Group, Inc. (NASDAQ:LFST) insider Lisa K. Miller sold 18,845 shares of the company’s stock in a transaction dated Monday, March 17th. The shares were sold at an average price of $6.90, for a total value of $130,030.50. Following the completion of the transaction, the insider now owns 339,810 shares in the company, valued at $2,344,689. This represents a 5.25 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

LifeStance Health Group Stock Up 0.1 %

Shares of LifeStance Health Group stock opened at $6.82 on Friday. The stock has a market capitalization of $2.62 billion, a P/E ratio of -26.23 and a beta of 1.27. The company has a quick ratio of 1.32, a current ratio of 1.32 and a debt-to-equity ratio of 0.19. The stock has a 50 day moving average price of $7.73 and a two-hundred day moving average price of $7.34. LifeStance Health Group, Inc. has a 12-month low of $4.64 and a 12-month high of $8.61.

Institutional Investors Weigh In On LifeStance Health Group

Large investors have recently added to or reduced their stakes in the stock. Geode Capital Management LLC boosted its position in LifeStance Health Group by 26.8% during the third quarter. Geode Capital Management LLC now owns 3,452,178 shares of the company’s stock worth $24,170,000 after purchasing an additional 729,794 shares during the period. Charles Schwab Investment Management Inc. lifted its holdings in shares of LifeStance Health Group by 36.9% during the third quarter. Charles Schwab Investment Management Inc. now owns 1,104,453 shares of the company’s stock worth $7,731,000 after buying an additional 297,723 shares during the last quarter. SG Americas Securities LLC lifted its holdings in shares of LifeStance Health Group by 65.7% during the fourth quarter. SG Americas Securities LLC now owns 90,355 shares of the company’s stock worth $666,000 after buying an additional 35,823 shares during the last quarter. JPMorgan Chase & Co. lifted its holdings in shares of LifeStance Health Group by 13.0% during the third quarter. JPMorgan Chase & Co. now owns 94,636 shares of the company’s stock worth $662,000 after buying an additional 10,894 shares during the last quarter. Finally, Point72 Asset Management L.P. lifted its holdings in shares of LifeStance Health Group by 24.9% during the third quarter. Point72 Asset Management L.P. now owns 1,100,441 shares of the company’s stock worth $7,703,000 after buying an additional 219,329 shares during the last quarter. Institutional investors own 85.50% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages recently commented on LFST. William Blair reissued an “outperform” rating on shares of LifeStance Health Group in a research note on Friday, February 28th. The Goldman Sachs Group raised LifeStance Health Group from a “neutral” rating to a “buy” rating and set a $10.00 price target for the company in a research note on Monday, December 16th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and three have given a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $8.63.

About LifeStance Health Group

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.